MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p [q] r s t u v w x y z
  • Quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson’s disease

    H.S. Dafsari, L. Weiss, M. Silverdale, P. Reddy, A. Rizos, M. Samuel, E. Perrier, J. Evans, K. Ashkan, J.N. Petry-Schmelzer, V. Visser-Vandewalle, A. Antonini, P. Martinez-Martin, K.R. Chaudhuri, L. Timmermann (Cologne, Germany)

  • Quality of life and epidemiological profile of patients undergoing botulinum toxin treatment

    G. Amorelli, L.F. Vasconcellos, M. Spitz, L.F. Fraga (Rio de Janeiro, Brazil)

  • Quality of life and living with Parkinson’s in Ireland

    I. Cassidy, P. Meskell, M.P. Butler, M. Richardson, C. Kennedy, S. Coote, P. Boers (Limerick, Ireland)

  • Quality of life of Parkinson’s disease patients in a tertiary hospital in Hong Kong

    H.F. Chan, Y.F. Cheung, D.K.W. Chau, T. Fung, I. Chan, W.C. Fong (Hong Kong, Hong Kong)

  • Quantifiable changes in cortical visual processing in patients with Parkinson’s disease but no cognitive impairment

    R.S. Weil, B. Bahrami, D.S. Schwarzkopf, H. Burn, J.D. Warren, H.R. Morris (London, United Kingdom)

  • Quantification of postural stability in Parkinson’s disease patients utilizing mobile technology

    J.L. Alberts, M.M. Koop, S.M. Linder, T. Dey, S.J. Ozinga (Cleveland, OH, USA)

  • Quantification of striatal dopamine transporters with [18F]PR04.MZ in patients with progressive supranuclear palsy and Parkinson’s disease

    P. Chana-Cuevas, C. Juri, V. Kramer, R. Pruzzo, P. Riss, A. Amaral, F. Rösch, H. Amaral (Santiago, Chile)

  • Quantification of tremor and rigidity during deep brain stimulation surgery for Parkison’s disease

    P. Poortvliet, A. Fytagoridis, T. Coyne, P. Silburn (Brisbane, Australia)

  • Quantifying daily living transitions in patients with Parkinson’s disease using a body-fixed sensor

    J.M. Hausdorff, H. Bernad-Elazari, T. Herman, A. Mirelman, E. Gazit, N. Giladi (Tel Aviv, Israel)

  • Quantifying turning behavior in Parkinson’s disease patients using mobile technology

    M. Miller Koop, S.J. Ozinga, J.L. Alberts (Cleveland, OH, USA)

  • Quantitative analysis of tremor in patients with cerebellar and brainstem lesions

    A. Kovács, Z. Farkas, A. Kamondi (Budapest, Hungary)

  • Quantitative assessment of advanced therapies in Parkinson’s disease using the Parkinson kinetigraph (PKG)

    R.L. Blaze, J. Tan, A.H. Evans (Parkville, Australia)

  • Quantitative assessment of DBS-induced gait disorder in patients with essential tremor

    D. Kroneberg, T. Schmitz-Hübsch, A. Gropp, G.H. Schneider, A.A. Kühn (Berlin, Germany)

  • Quantitative measurements of deficit type and severity in focal embouchure dystonia

    A.E. Morris, S.D. Anderson, J.W. Mink (Rochester, NY, USA)

  • Quantitative MRI measurement of regional cerebellar involvement in patients with progressive supranuclear palsy

    Y. Lee, D.K. Lee, J.M. Lee, S.J. Chung, J.J. Lee, Y.H. Sohn, P.H. Lee (Seoul, Korea)

Jump to:  View All • a b c d e f g h i j k l m n o p [q] r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley